New preclinical results optimal for the NEX-18 project
News
Uppsala 16th January 2019
New preclinical results optimal for the NEX-18 project
Nanexa has today obtained results from a preclinical pharmacokinetic study (a so-called PK study) in the rat with its drug delivery system PharmaShell®.
Nanexa invests to meet increased demand
Pressrelease
Uppsala 7th January 2019
Nanexa invests to meet increased demand
Nanexa has placed an order for another reactor for Atomic Layer Deposition (ALD) from the Finnish company Picosun.
